Here are relevant reports on : hedge-fund-administration-market
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral)- Global Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
APAC Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The APAC injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
IoT in Education Market by Component (Hardware, Solutions & Services), End User (Academic Institutions & Corporates), Application (Learning Management, Classroom Management, Administration Management & Surveillance), and Region - Global Forecast to 2023
The global IoT in education market size is expected to grow from USD 4.8 billion in 2018 to USD 11.3 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 18.8% during the forecast period. Major growth factors for the IoT in education market include an increased use of connected devices in the education institutions, rapid adoption of eLearning, and availability of cloud-based solution. Major vendors covered in the IoT in education market include Google (US), Amazon Web Services (US), IBM (US), Microsoft (US), Oracle (US), Intel (US), Cisco (US), SAP (Germany), Huawei (China), Arm (UK), Unit4 (Netherlands), and Samsung (South Korea).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Forecast to 2031
The Asia Pacific pharmaceutical drug delivery market, valued at US$457.9 million in 2025, stood at US$479.7 million in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of US$687.9 million by the end of the period. The market growth for drug delivery in the APAC region is steadily expanding due to an increase in disease prevalence, an increase in the adoption rate of biologics, advancements in technologies, and an increase in regional production.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Railway Cybersecurity Market by Type (Infrastructural & On-board), Offering, Security Type (Network, Application, Endpoint, System Administration and Data Protection), Application (Passenger & Freight), Rail Type and Region - Global Forecast to 2027
The Railway Cybersecurity Market is expected to grow from USD 6.2 billion in 2021 to USD 10.6 billion by 2027, at a CAGR of 9.4% during the forecast period. The report analyzes all major players in the railway cybersecurity market including Thales Group (France), Siemens AG (Germany), Alstom (France), Wabtec (US), and Nokia Networks (Finland).
- Published: July 2021
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at US$3.84 billion in 2025, stood at US$4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of US$5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pediatric Vascular Access Market by Type (Catheters (CVC, PIVC, PICC), Ports, IV Sets, Infusion Pumps), Application (Drug Administration, Blood Transfusion, Diagnostics & Testing), End User (Hospitals, ASCs) - Global Forecast to 2030
The global pediatric vascular access market, valued at US$0.51 billion in 2023, stood at US$0.54 billion in 2024 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$0.83 billion by the end of the period. The market for pediatric vascular access is driven by the increasing prevalence of preterm births, and advancements in pediatric care technologies are key factors fueling the growth of the pediatric vascular access market.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
